⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 15, 2001European Heart JournalOpen Access

Molecular analysis of connexin 40 in the familial form of atrial fibrillation

Juliette Lamarche

View Full Paper

Ask AI

Bookmark

Share

Abstract

J. Lamarche, G. O'Hara, F. Philippon, M. Gilbert, P. Daleau; Molecular analysis of connexin 40 in the familial form of atrial fibrillation, European Heart Journ

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Juliette Lamarche (2001) studied this question.

synapsesocial.com/papers/6a994042bd35225844190895 https://doi.org/10.1053/euhj.2001.2668

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Real-world use of bempedoic acid for ASCVD risk reduction in a rural UK primary care practice: Analysing trends in LDL-C reduction, adherence, and ESC target attainmentEuropean Heart Journal · Thu,
2Differences of the characteristics of uncontrolled versus controlled hypertensive patients, treated with at least three antihypertensive drugs: insights from the SNAPSHOT Europe studyEuropean Heart Journal · Thu,
3Inflammatory burden, but not genetic variation, predicts attenuated LDL cholesterol reduction after ST-elevation myocardial infarctionEuropean Heart Journal · Thu,
4Predictors of atrial fibrillation development in patients with chronic cardiorenal syndromeEuropean Heart Journal · Thu,
5Perception of self-efficacy improves adherence in hypertensive patientsEuropean Heart Journal · Thu,

More from European Heart Journal

A data-driven multivariate bleeding risk model incorporating modifiable and non-modifiable bleeding risk factors: the GLORIA-AF bleeding risk scoreThu,
The "binary switch" of vascular aging: coronary artery calcium presence, but not density or volume, predicts exaggerated blood pressure response during exerciseThu,
ILC2-derived IL-9 activates regulatory T cells to facilitate post-myocardial infarction repairThu,
Clinical profile and determinants of NECPAL positivity in advanced cardiorenal syndrome: a prospective multicentre studyThu,
Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS studyThu,